Literature DB >> 27866029

Understanding the structural features of symptomatic calcific aortic valve stenosis: A broad-spectrum clinico-pathologic study in 236 consecutive surgical cases.

Daniela Galli1, Roberta Manuguerra2, Rodolfo Monaco2, Laura Manotti2, Matteo Goldoni3, Gabriella Becchi2, Cecilia Carubbi1, Giulia Vignali4, Nicola Cucurachi4, Tiziano Gherli5, Francesco Nicolini5, Roberto Lorusso6, Marco Vitale7, Domenico Corradi8.   

Abstract

BACKGROUND: With age, aortic valve cusps undergo varying degrees of sclerosis which, sometimes, can progress to calcific aortic valve stenosis (AVS). To perform a retrospective clinico-pathologic investigation in patients with calcific AVS.
METHODS: We characterized and graded the structural remodeling in 236 aortic valves (200 tricuspid and 36 bicuspid) from patients with calcific AVS (148 males; average 72years); possible relationships between general/clinical/echocardiographic characteristics and the histopathologic changes were explored. Twenty autopsy aortic valves served as controls. In 40 cases, we also tested the immunohistochemical expression of metalloproteinases and cytokines, and characterized the inflammatory infiltrate. In 5 cases, we cultured cusp stem cells and explored their potential to differentiate into osteoblasts/adipocytes.
RESULTS: AVS cusps showed structural remodeling as severe fibrosis (100%), calcific nodules (100%), neoangiogenesis (81%), inflammation (71%), bone metaplasia with or without hematopoiesis (6% and 53%, respectively), adipose metaplasia (16%), and cartilaginous metaplasia (7%). At multivariate analysis, AVS degree and interventricular septum thickness were the only predictors of remodeling (barring inflammation). All the tested metalloproteinases (except MMP-13) and cytokines were expressed in AVS cusps. Inflammation mainly consisted of B and T lymphocytes (CD4+/CD8+ cell ratio 3:1) and plasma cells. AVS changes were mostly different from typical atherosclerosis. Cultured mesenchymal cusp stem cells could differentiate into osteoblasts/adipocytes.
CONCLUSIONS: Structural remodeling in AVS is peculiar and considerable, and is related to the severity of the disease. However, the different newly formed tissues-where "valvular interstitial cells" play a key role-and their well-known slow turnover suggest a reverse structural remodeling improbable.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Aortic valve stenosis; Histopathology; Osseous metaplasia; Structural remodeling; Valvular interstitial cells

Mesh:

Year:  2016        PMID: 27866029     DOI: 10.1016/j.ijcard.2016.11.180

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

1.  Non-pathological Chondrogenic Features of Valve Interstitial Cells in Normal Adult Zebrafish.

Authors:  Alina Schulz; Jana Brendler; Orest Blaschuk; Kathrin Landgraf; Martin Krueger; Albert M Ricken
Journal:  J Histochem Cytochem       Date:  2019-01-08       Impact factor: 2.479

2.  Increased Calcific Aortic Valve Disease in response to a diabetogenic, procalcific diet in the LDLr-/-ApoB100/100 mouse model.

Authors:  Marta Scatena; Melissa F Jackson; Mei Y Speer; Elizabeth M Leaf; Mary C Wallingford; Cecilia M Giachelli
Journal:  Cardiovasc Pathol       Date:  2018-02-15       Impact factor: 2.185

Review 3.  A feedback loop: Interactions between Inflammatory Signals and Clonal Hematopoiesis in Cardiovascular Disease.

Authors:  Jiashan Li; Chao Wang; Jiaru Liu; Ying Yu; Yuee Liu; Qi Peng; Huihui Liu; Xiuru Guan
Journal:  Mol Biol Rep       Date:  2021-05-13       Impact factor: 2.316

4.  Elimination of macrophages reduces glutaraldehyde-fixed porcine heart valve degeneration in mice subdermal model.

Authors:  Zongtao Liu; Yixuan Wang; Fei Xie; Xing Liu; Fei Li; Nianguo Dong
Journal:  Pharmacol Res Perspect       Date:  2021-02

5.  Cardio-Oncology: A Myriad of Relationships Between Cardiovascular Disease and Cancer.

Authors:  Yinghui Wang; Yonggang Wang; Xiaorong Han; Jian Sun; Cheng Li; Binay Kumar Adhikari; Jin Zhang; Xiao Miao; Zhaoyang Chen
Journal:  Front Cardiovasc Med       Date:  2022-03-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.